Now a third option is available after the U.S. Food and Drug Administration last week approved Vertex Pharmaceuticals’ Suzetrigine, sold as twice-daily Journavx, a non-addictive prescription drug for ...

What happened to Darvon? It wasn’t addicting and didn’t cost much, and I never heard any reason why it was withdrawn except that “it didn’t work.” It sure ...

A new painkiller that is said to be free of addiction risks may be transformative for treatment of acute pain, according to local medical professionals. "I think it could be a potentially ...

Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll ...

A Williamsburg-based recovery advocate said she hopes the money will help local families and communities impacted by the crisis.

A Williamsburg-based recovery advocate said she hopes the money will help local families and communities impacted by the crisis.

U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...

The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or ...

This is both a pity and not entirely surprising. Because the Sacklers are at the centre of a huge scandal over painkilling drugs – specifically OxyContin, a powerful opioid developed by the family’s ...